BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23658133)

  • 1. Collagen triple helix repeat containing-1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features.
    Kim JH; Baek TH; Yim HS; Kim KH; Jeong SH; Kang HB; Oh SS; Lee HG; Kim JW; Kim KD
    Pathol Oncol Res; 2013 Oct; 19(4):731-7. PubMed ID: 23658133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
    Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
    J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
    Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma.
    Li N; Chen L; Liu C; Jiang Y; Rong J
    Hum Pathol; 2019 Mar; 85():235-241. PubMed ID: 30381261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.
    Ke Z; He W; Lai Y; Guo X; Chen S; Li S; Wang Y; Wang L
    Oncotarget; 2014 Oct; 5(19):9410-24. PubMed ID: 25238260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
    Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
    J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cthrc1 overexpression is an independent prognostic marker in gastric cancer.
    Gu L; Liu L; Zhong L; Bai Y; Sui H; Wei X; Zhang W; Huang P; Gao D; Kong Y; Lou G
    Hum Pathol; 2014 May; 45(5):1031-8. PubMed ID: 24746208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study.
    Kharaishvili G; Cizkova M; Bouchalova K; Mgebrishvili G; Kolar Z; Bouchal J
    J Clin Pathol; 2011 Nov; 64(11):977-82. PubMed ID: 21742751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.
    Hou M; Cheng Z; Shen H; He S; Li Y; Pan Y; Feng C; Chen X; Zhang Y; Lin M; Wang L; Ke Z
    Oncotarget; 2015 Nov; 6(34):35813-29. PubMed ID: 26452130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTHRC1 expression is a novel shared diagnostic and prognostic biomarker of survival in six different human cancer subtypes.
    Sial N; Ahmad M; Hussain MS; Iqbal MJ; Hameed Y; Khan M; Abbas M; Asif R; Rehman JU; Atif M; Khan MR; Hameed Z; Saeed H; Tanveer R; Saeed S; Sharif A; Asif HM
    Sci Rep; 2021 Oct; 11(1):19873. PubMed ID: 34615943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
    Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
    BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of CTHRC1 predicts unfavorable prognosis in patients with pancreatic ductal adenocarcinoma.
    Liu W; Fu XL; Yang JY; Yang MW; Tao LY; Liu DJ; Huo YM; Zhang JF; Hua R; Sun YW
    Am J Cancer Res; 2016; 6(8):1820-7. PubMed ID: 27648368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen Triple Helix Repeat Containing 1 Expression in Osteosarcoma: A New Predictor of Prognosis.
    Liu Y; Abulimiti N; Wang C
    Ann Clin Lab Sci; 2018 May; 48(3):338-344. PubMed ID: 29970438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers.
    Tang L; Dai DL; Su M; Martinka M; Li G; Zhou Y
    Clin Cancer Res; 2006 Jun; 12(12):3716-22. PubMed ID: 16778098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen triple helix repeat containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells.
    Kim HC; Kim YS; Oh HW; Kim K; Oh SS; Kim JT; Kim BY; Lee SJ; Choe YK; Kim DH; Kim SH; Chae SW; Kim KD; Lee HG
    Oncotarget; 2014 Jan; 5(2):519-29. PubMed ID: 24504172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.
    Huang GL; Zhang XH; Guo GL; Huang KT; Yang KY; Shen X; You J; Hu XQ
    Oncol Rep; 2009 Mar; 21(3):673-9. PubMed ID: 19212625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of CacyBP is associated with poor prognosis and the effects on COX-2 expression in breast cancer.
    Nie F; Yu XL; Wang XG; Tang YF; Wang LL; Ma L
    Int J Oncol; 2010 Nov; 37(5):1261-9. PubMed ID: 20878073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
    Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
    J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.